PODD : Summary for Insulet Corporation - Yahoo Finance

U.S. Markets close in 2 hrs 40 mins

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.06+0.56 (+1.35%)
As of 1:20PM EDT. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close41.50
Bid42.03 x 100
Ask42.08 x 100
Day's Range41.91 - 42.61
52 Week Range26.50 - 48.23
Avg. Volume435,735
Market Cap2.43B
PE Ratio (TTM)-83.45
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?
    Motley Fool11 days ago

    Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?

    Medtronic's MiniMed 670G could reduce the burden on Type 1 diabetes patients, as well as slow diabetes progression by keeping blood glucose levels on target.

  • American City Business Journals14 days ago

    ​Medical device firm Insulet opening manufacturing site in Acton

    Billerica-based Medical device firm Insulet Corp. will soon break ground on a new manufacturing facility in Acton and could move its headquarters there in the future, a spokeswoman said. Insulet (PODD), which moved its headquarters from Bedford to Billerica in 2014, purchased the 195,000 square foot facility in December 2016 for $9.3 million as part of a plan to start manufacturing in the U.S. for the first time in addition to China, where its Omnipod insulin pumps are currently made by contractors.

  • Capital Cube17 days ago

    ETFs with exposure to Insulet Corp. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Insulet Corp. Here are 5 ETFs with the largest exposure to PODD-US. Comparing the performance and risk of Insulet Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)